Synthetic peptide within Human ADCY9 aa 1303-1353 (C terminal). The exact sequence is proprietary. (NP_001107.2)
Sequence:
DAHLSPKRPWKEPVKAEERGRFGKAIEKDDCDETGIEEANELTKLNVSKS V
Our Abpromise guarantee covers the use of ab191213 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
IP | Use at 2-10 µg/mg of lysate. | |
WB | 1/2000 - 1/10000. Predicted molecular weight: 151 kDa. |
Immunoprecipitation analysis of HeLa cell lysate (in RIPA buffer, 0.5 or 1.0 mg per IP reaction; 20% of IP loaded) labeling ADCY9 using ab191213 at 6 μg per reaction (lane 2). An other rabbit antibpdy against ADCY9 was used in Lane 1. A Control IgG was used in lane 3. For blotting immunoprecipitated ADCY9, ab191213 was used at 0.4 μg/ml. Detection: Chemiluminescence with an exposure time of 30 seconds.
ab191213 has not yet been referenced specifically in any publications.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"